Gel Mark Ultra Biopsy Site Marker - Marker, lesion localization, implantable

البلد: أستراليا

اللغة: الإنجليزية

المصدر: Department of Health (Therapeutic Goods Administration)

متاح من:

Bard Australia Pty Ltd

الفئة:

Class III

المصنعة من قبل:

SenoRx Inc 1625 W 3rd Street, Tempe, AZ, 82581 United States Of America

المجال العلاجي:

40808 - Marker, lesion localization, implantable

الخصائص العلاجية:

A disposable applicator containing resorbable polylactic acid/polyglycolic acid (PLA/PGA) pellets with an embedded stainless steel radiopaque wireform, intended for long term radiographic marking of the biospy site. Pellets are visible via ultrasound for approx. 6 weeks and resorbed in approx. 12 weeks. The pellets are deployed from the applicator through the biopsy device into the biopsy cavity. An implant used to radiographically mark breast tissue during a percutaneous breast biopsy procedure.

الوضع إذن:

A

تاريخ الترخيص:

2009-03-11